SCHEMBL14499415

SCHEMBL14499415

O/N=C\c1ccc(OC2CCCCO2)cc1

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.39
MAPT P10636 3/20 0.39
MEN1 O00255 2/20 0.39
ALDH1A1 P00352 2/20 0.39
TNK2 Q07912 3/20 0.36
KDM4E B2RXH2 1/20 0.36
RAB9A P51151 3/20 0.36
HSD11B1 P28845 1/20 0.36
NPC1 O15118 1/20 0.35
CASP3 P42574 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
GFER P55789 1/20 0.35
GAA P10253 1/20 0.35
DHFR P00374 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5642392 1.00 KMT2A (0.39) KMT2AMAPTMEN1ALDH1A1TNK2
SCHEMBL14499417 1.00 KMT2A (0.39) KMT2AMAPTMEN1ALDH1A1TNK2
SCHEMBL5638611 0.83 TNK2 (0.35) KMT2AMEN1ALDH1A1TNK2KDM4E
SCHEMBL3500438 0.82 TNK2 (0.44) KMT2AMEN1ALDH1A1TNK2KDM4E
SCHEMBL9876349 0.80 KDM4E (0.39) KMT2AMEN1ALDH1A1TNK2KDM4E
SCHEMBL412542 0.80 ALDH1A1 (0.39) KMT2AMEN1ALDH1A1TNK2KDM4E
SCHEMBL863095 0.80 ALDH1A1 (0.58) KMT2AMEN1ALDH1A1TNK2KDM4E
SCHEMBL6163169 0.79 SCN4A (0.50) KMT2AMAPTALDH1A1KDM4ERAB9A
SCHEMBL222919 0.78 MEN1 (0.43) KMT2AMEN1ALDH1A1TNK2RAB9A
SCHEMBL15093765 0.78 MEN1 (0.43) KMT2AMEN1ALDH1A1TNK2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7229987-B2 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes ELI LILLY AND COMPANY (US) 2007-06-12 US disclosed
US-7229987-B2 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes ELI LILLY AND COMPANY (US) 2007-06-12 US disclosed